Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ERAS stock hub

Erasca, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ERASis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ERAS

In the news

Latest news · ERAS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-33.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-19.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ERAS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001761918
Company name	Erasca, Inc.
Country	United States
Country code	US
Cusip	29479A108
Employees	103
Employees Change	-23%
Employees Change Percent	-18.25
Enterprise value	$2.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-16
Isin	US29479A1088
Last refreshed	2026-05-10
Market cap	$3.1B
Market cap category	Mid-Cap
Price	$10.12
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ERAS
Website	https://www.erasca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.96%
FCF yield	-3.04%
P/B ratio	8.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-124.5M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Profit Per Employee	$-1.2M
ROA	-18.28
Roa5y	-19.27
ROCE	-35.74
ROE	-33.27
Roe5y	-42.12
ROIC	-19.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	727.32%
Cagr3y	51.32%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$396.2M
Cash	$276.1M
Current Assets	$286.2M
Current Liabilities	$28.5M
Debt	$47.1M
Debt Equity	$0.14
Equity	$325.2M
Liabilities	$71M
Long Term Assets	$109.9M
Long Term Liabilities	$42.5M
Net Cash	$294.7M
Net Cash By Market Cap	$9.36
Net Cash Growth	-24.17%
Net Debt Equity	$-0.91
Tangible Book Value	$325.2M
Tangible Book Value Per Share	$1.14
WACC	7.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.04
Net Working Capital	$-13.3M
Quick ratio	9.77
Working Capital	$257.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	726.12%
200-day SMA	7.04
3Y total return	246.58%
50-day SMA	15.39
50-day SMA vs 200-day SMA	50over200
All Time High	24.47
All Time High Change	-58.64%
All Time High Date	2021-09-07
All Time Low	1.01
All Time Low Change	901.98%
All Time Low Date	2025-04-09
ATR	1.73
Beta	0.68
Beta1y	1.19
Beta2y	1.76
Ch YTD	172
High	10.54
High52	24.28
High52 Date	2026-04-23
High52ch	-58.32%
Low	9.94
Low52	1.06
Low52 Date	2025-05-27
Low52ch	854.72%
Ma50ch	-34.25%
Premarket Change Percent	1.35
Premarket Price	$10.54
Premarket Volume	21,047
Price vs 200-day SMA	43.69%
RSI	35.09
RSI Monthly	61.05
RSI Weekly	48.91
Sharpe ratio	2.48x
Sortino ratio	4.24
Total Return	-21.26%
Tr YTD	172
Tr1m	-40.68%
Tr1w	0.9%
Tr3m	-17.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	7
Analyst Price Target Top	$17.14
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.22
Operating Income	$-131.4M
Price target	$15
Price Target Change	$48.22
Price Target Change Top	$69.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	225,975,905%
Float Percent	72.67%
Shares Insiders	10.85%
Shares Institutions	58.21%
Shares Out	310,965,971
Shares Qo Q	0.05%
Shares Yo Y	21.26%
Short Float	15.03%
Short Ratio	5.66
Short Shares	10.93

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-120.5M
Average Volume	10,540,586.35x
Bv Per Share	1.14
CAPEX	$-128,000
Ch1m	-40.68
Ch1w	0.9
Ch1y	726.1
Ch3m	-17.66
Ch3y	246.6
Ch6m	345.8
Change	-2.69%
Change From Open	-3.34
Close	10.4
Days Gap	0.67
Depreciation Amortization	3,107,000
Dollar Volume	31,722,344.3
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-131.4M
EBITDA	$-128.3M
EPS	$-0.44
F Score	2
FCF	$-95.6M
FCF EV Yield	-3.35x
FCF Per Share	$-0.31
Financing CF	1,096,000
Fiscal Year End	December
Founded	2,018
Investing CF	100,425,000
Ipr	-36.75
Iprfo	-36.35
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	8.84
Ma150ch	14.45%
Ma20	15.49
Ma20ch	-34.65%
Net CF	6,066,000
Next Earnings Date	2026-05-22
Open	10.47
Optionable	Yes
Position In Range	30
Post Close	10.12
Postmarket Change Percent	0.67
Postmarket Price	$10.19
Ppne	42,333,000
Pre Close	10.4
Price Date	2026-05-08
Ptbv Ratio	9.68
Relative Volume	0.3x
Share Based Comp	24,899,000
Tr6m	345.82%
Us State	California
Volume	3,134,619

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ERAS pay a dividend?

Capital-return profile for this ticker.

Performance

ERAS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ERAS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.2%

Float: +72.7% of shares outstanding

Insider ownership

+10.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ERAS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.1

Neutral momentum band

Price vs 200-day MA

+43.7%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

2.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ERAS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ERAS stock rating?

Erasca, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ERAS analysis?

The full report lives at /stocks/ERAS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ERAS?

The latest report frames ERAS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ERAS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.